Lo studio su mille campioni di sangue, a cui si riferisce Cristian Martini Grimaldi nell'art. pubblicato oggi su La Stampa e ripreso da altre testate giornalistiche, è scaricabile da "medRxiv" come rapporto preliminare (preprint):
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
"Funding Statement The study was conducted using unrestricted research funds of Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, provided by Tsumura & Co. and Takasago Seibu Hospital."
"Competing Interest Statement The authors have declared no competing interest."
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
"Funding Statement The study was conducted using unrestricted research funds of Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, provided by Tsumura & Co. and Takasago Seibu Hospital."
"Competing Interest Statement The authors have declared no competing interest."
Comments